Brazil’s luxury market is expanding despite global softness, and a stronger IP toolkit—position marks, trade dress, copyright, border measures, and favorable court rulings—is shaping a robust anti-counterfeiting environment.

Cybersecurity’s rise as a national-security imperative revives debate on compulsory licensing, but because effective defense depends on trade secrets and operational know-how, any emergency use must be narrowly tailored to avoid exposing sensitive methods while preserving incentives for R&D and cooperation with rightsholders.

ANVISA’s new 2025–2026 Operational Tactical Plan aims to reduce marketing approval backlogs by allowing applicants to replace pending submissions before formal review and by granting priority review for GLP‑1 receptor agonists.

The scientific significance of microbial consortia, their applications in biotechnology, and the challenges of obtaining patent protection in Brazil under BRPTO regulations.

A new chapter in Brazil’s IP scene has begun with the launch of RNA Law, an elite boutique firm dedicated to IP litigation, prosecution, and transactions.

BRPTO introduces a new appeal stage workflow to improve patent examination, focusing on enhancing consistency and efficiency in Brazil’s patent appeal process

Brazilian Congress to debate whether AI can be recognized as an inventor in patents

Explores the impact of Brazil’s updated rules on administrative appeals and their implications for patent stakeholders.

Comparative analysis of sequence listing requirements in divisional patent applications between EPO and BRPTO.

Projeto de Lei apresentado na Câmara propõe alteração na Lei da Propriedade Industrial

Governo lança programa "Mover" para promover sustentabilidade em automóveis, investimentos em P&D e atrair plantas industriais estrangeiras.

Antes da ampla adoção de computadores quânticos, há necessidade de padronização e desenvolvimento de técnicas de criptografia mais complexas para eliminar riscos à privacidade

Legal implications and challenges of quantum computing and AI in Brazil

Risks associated with evolving biosimilar regulations and pharmacovigilance in Brazil

Examination of how COVID-19 has affected IP law and practice in Brazil

Brazil prepares to introduce regulations for cannabis-based pharmaceuticals

The Brazilian Supreme Court case that could reshape the country’s patent system

Brazil’s Supreme Court sets earlier date for deciding 10-year patent term fate

Bolsonaro vetoes Brazil’s pioneering compulsory tech transfer law, sparking debate

Practical tips following Brazil’s impactful patent term decision

Strategies for obtaining patents using post-filing experimental evidence in Brazil

Brazil seeks to implement new regulations for “skinny labels” in pharmaceuticals

Update on preliminary injunctions in Brazil’s biotechnology and pharmaceutical patent litigation

Brazil’s growing favorability as a jurisdiction for life sciences patents